Thrombotic thrombocytopenic purpura and neurologic manifestations â€“ Case report and integrative review
Keywords:purpura, neurologic manifestations, headache
Introduction: Thrombotic thrombocytopenic Purpura (TTP) is a rare and pontentially life-threatening condition, it occurs due a deficiency of ADAMTS13 enzyme complex, leading to formation of microthrombi in the microvasculature, what may cause manifestations in several organs. The most common tissues afected are the renal and neurological ones, with some severe complications. The best treatmente nowadays is Plasma Exchange (PEx). The most commom neurologic manifestation of TTP is Headache, but stroke, mental confusion and others can also be present. Objective: To describe a case of atypical neurologic manifestation of TTP and to perform na integrative review. Case Report: Female patient, 59 years old was admitted to the emergency room with importante dyspneia. She also presented hypotension, tachycardia and low oxygen-hemoglobin saturation. After these symptoms were estabilized, she was hospitalized for further investigation. During her hospitalization, she developed microangiophatic anemia, thrombocytopenia and renal failure, she also had a historic of neurologic manifestations such as strenght decrease in lower and upper limbs, gagging, dysphagia. She was diagnosed with TTP and and it was indicated hospital transference to her for realizing this procedure, Although, in the thirteenth day of hospitalization, the patient had and irreversible cardiac arrest. Discussion: The Thrombotic thrombocytopenic purpura is a rare disease that affects priorly women and its a rara condition in many countries around the world. We present a case of atypical neurologic manifestations in a patient with no risk factors. We also know that this disease is treatable with Plasma Exchange and this procedure changed the morality rate which used to be about 80% and after PEX is about of 20%. The most common neurologic manifestation is headache. Conclusion: We have to be alert in patients in the emergency departament with neurologic manifestations. Once the patient did not present any of the most commom neurologic symptons, it is a rare case.
Mariotte E, et al. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deï¬ciency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national
George JN. Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2013; 354(18): 1927-35
Deford CC, et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19;122(12): 2023-9
Sayani AF, Abrams CS. How i treat refractory thrombotic thrombocytopenic purpura. Blood. 2015 Mar 17; 125(25): 3860-7
Peyvand F. et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2016 Feb 11; 374(6): 511-22
Mannucci PM, Cugno M. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Thromb Res. 2015 Nov; 136(5): 851-4
Saultz JN, Haifeng MW, Cataland S. Headache prevalence following recovery from TTP and aHUS. Ann Hematol 2015 May 28;
Balduini CL, et al. High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. Ann Hematol. 2010 Jun; 89(6):591-6
Williams LA, Marques MB. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs). Am J Clin Pathol February 2016;145:158-165
Tsai HM. The Molecular Biology of Thrombotic Microangiopathy. Kidney Int. 2006 July ; 70(1): 16â€“23.
Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med 2006;57:419â€“ 436
Paula Vieira-Martins, Carine El Sissy, Pauline Bordereau, Aurelia Gruber, Jeremie Rosain, Veronique Fremeaux-Bacchi, Defining the genetics of thrombotic microangiopathies, Transfusion and Apheresis Science (2016)
Tarniceriu et al. Thrombotic thrombocytopenic purpura: a hematological emergency. Rom J Morphol Embryol 2014, 55(3 Suppl):1259â€“1262
Burrus TM, et al. Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol. 2010 Jul;67(7):831-4
Bezov D, et al. Headache in thrombotic thrombocytopenic purpura: two cases with pathophysiological considerations. Headache. 2010 Jun;50(6):1060-
Mehmood T, Taylor M, Winters JL. Management of thrombotic microangiophatic hemolytic anemias with therapeutic plasma exchange, when it works and when it does not. Hematol Oncol Clin N Am. 2016 Jun;30(3):679-94
Binder et al. Case 37-2010: a 16-Year-Old girl with confusion, anemia, and thrombocytopenia. N Engl J Med 2010; 363:2352-2361
Garcia G, Atallah JP. Antineoplastic agents and thrombotic microangiopathy. J Oncol Pharm Practice 2016 Feb 11; 0(0): 1â€“8
Bellante F, Redondo Saez P, Springael C, Dethy S. Stroke in thrombotic thrombocytopenic purpura induced by thyrotoxicosis: a case report. J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1744-6
Hovinga JAK et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb; 115(8): 1500-11
Ramakrishnan Geethakumari P, Rubin A, Varadi G. Thrombotic thrombocytopenic purpura and cardiac papillary fibroelastoma: a 'unique coexistence'. Blood Coagul Fibrinolysis. 2013 Dec;24(8):881-3
Sandouk Z, et al. DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?. BMJ Case Rep. 2012 Nov; 2012: bcr2012007558
Mehta N, Saxena A, Niesvizky R. Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ Case Rep. 2012 Aug; 2012: bcr2012006461
Patel P, et al. Unscripted. J Hosp Med. 2010 Jul-Aug;5(6):366-70
De Jong FJ, et al. Coma in thrombotic thrombocytopenic purpura. BMJ Case Rep. 2010 Nov; 2010: bcr0620103113
Thomas MP, Wang A. Clinical problem-solving. Taken out of context. N Engl J Med. 2008 Dec 4;359(23):2478-82
McCormick JK, Nadel ES, Brown DFM. Rash and Neurological Symptoms. The Journal of Emergency Medicine. 2007; 32(3): 299-303
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).